{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "type": "composite", "version": "1", "versioncreated": "2026-08-11T03:18:11.028006Z", "firstcreated": "2026-08-11T03:12:29.804460Z", "pubstatus": "usable", "language": "en", "headline": "How Much Longer Could Humans Live by 2050?", "description_text": "Aging research has moved from mice into human trials. The likeliest 2050 outcome is not immortality, but a stack of therapies that may add healthy years — with cost and access depending heavily on which technologies succeed.", "associations": {"item-0": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:881a36ff-e1a7-4153-a400-5d124dece016", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T20:19:05.798169Z", "firstcreated": "2026-08-11T03:12:29.804460Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "How Much Longer Could Humans Live by 2050?", "byline": "Jordan Quincy", "located": "United States", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Science Official", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Science Official”. Set rel=canonical to https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/ when publishing on the web.", "description_text": "Aging research has moved from mice into human trials. The likeliest 2050 outcome is not immortality, but a stack of therapies that may add healthy years — with cost and access depending heavily on which technologies succeed.", "altids": {"mosaic": "881a36ff-e1a7-4153-a400-5d124dece016", "story": "e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050"}, "subject": [{"name": "Science", "rel": "direct", "literal": "science", "code": "medtop:13000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/13000000"}], "place": [{"name": "United States", "literal": "us", "code": "US", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:59b01ae1-1c9b-4791-975f-dfb3aa45d49d", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "aarp.org", "copyrightnotice": "Image credit: Rory Doyle / AARP", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "59b01ae1-1c9b-4791-975f-dfb3aa45d49d"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "Reuse rights confirmed for editorial use", "licence_verified_at": "2026-08-21T20:19:06.051206Z", "attribution_required": true, "attribution_text": "Image credit: Rory Doyle / AARP", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "aarp.org", "source_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "source_page_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "our_page_url": "https://ascensio.uno/stile-di-vita/nel-2050-potremmo-non-vivere-150-anni-ma-invecchiare-molto-piu-tardi/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050-20260811", "status": "closed", "languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "item_count": 13, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Science Official", "canonical_required": true, "canonical_url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 8, "official_source_used": false, "used_press_release": false, "public_interest": false, "ai_disclosure_required": false, "ai_disclosure_text": "", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-08-21T20:19:05.810853Z"}, "sources": [{"url": "https://clinicaltrials.gov/study/NCT07290244", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.799947Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT06658093", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.800357Z", "published_at": null}, {"url": "https://www.nia.nih.gov/research/blog/2026/03/are-you-developing-drugs-target-aging-mechanisms-nia-wants-hear-you", "title": "", "publisher": "nia.nih.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.800683Z", "published_at": null}, {"url": "https://www.nature.com/articles/s43587-022-00357-y", "title": "", "publisher": "nature.com", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.801031Z", "published_at": null}, {"url": "https://www.afar.org/tame-trial", "title": "", "publisher": "afar.org", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.801343Z", "published_at": null}, {"url": "https://pubmed.ncbi.nlm.nih.gov/41985884/", "title": "", "publisher": "pubmed.ncbi.nlm.nih.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.801630Z", "published_at": null}, {"url": "https://www.nature.com/articles/s41591-024-03096-2", "title": "", "publisher": "nature.com", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.801923Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT07195318", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.802196Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT06431932", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.802451Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT03675724", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.802703Z", "published_at": null}, {"url": "https://www.nature.com/articles/s43587-022-00183-2", "title": "", "publisher": "nature.com", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.802944Z", "published_at": null}, {"url": "https://www.nature.com/articles/s43587-023-00528-5", "title": "", "publisher": "nature.com", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.803204Z", "published_at": null}, {"url": "https://www.lifebiosciences.com/life-biosciences-announces-first-patient-dosed-in-phase-1-trial-of-er-100-for-optic-neuropathies/", "title": "", "publisher": "lifebiosciences.com", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.803445Z", "published_at": null}, {"url": "https://www.retro.bio/blog/fundraise-2026", "title": "", "publisher": "retro.bio", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.803742Z", "published_at": null}, {"url": "https://www.retro.bio/pipeline", "title": "", "publisher": "retro.bio", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.803995Z", "published_at": null}, {"url": "https://www.nature.com/articles/s41591-026-04254-4", "title": "", "publisher": "nature.com", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.804252Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT06878560", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.804490Z", "published_at": null}, {"url": "https://ir.unither.com/press-releases/2026/05-15-2026-230017490", "title": "", "publisher": "ir.unither.com", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.804742Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/innovation-models/cgt", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.805038Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/cgt-access-model-frequently-asked-questions", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.805314Z", "published_at": null}, {"url": "https://www.nature.com/articles/s43587-024-00702-3", "title": "", "publisher": "nature.com", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.805562Z", "published_at": null}, {"url": "https://www.nature.com/articles/s43587-021-00080-0", "title": "", "publisher": "nature.com", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.805822Z", "published_at": null}]}, "wireva:publication": {"name": "Science Official", "domain": "scienceofficial.org", "country": "US", "url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/881a36ff-e1a7-4153-a400-5d124dece016", "html": "https://wireva.mib.news/item/881a36ff-e1a7-4153-a400-5d124dece016/how-much-longer-could-humans-live-by-2050/", "story": "https://wireva.mib.news/story/how-much-longer-could-humans-live-by-2050-20260811/"}, "wireva:metrics": {"word_count": 1751, "char_count": 11859, "reading_time_seconds": 847}}}, "item-1": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:36632fdb-3c80-4539-ab23-bb474615618e", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T20:19:05.828200Z", "firstcreated": "2026-08-11T03:18:10.693740Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "The Longevity Boom Is Moving From Supplements to Clinical Medicine", "byline": "Blake Kendall", "located": "United States", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Boldest Voice", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Boldest Voice”. Set rel=canonical to https://boldestvoice.com/technology/the-longevity-boom-is-moving-from-supplements-to-clinical-medicine/ when publishing on the web.", "description_text": "By 2050, the realistic prize may be years of healthier life rather than 150-year lifespans — and the first effective therapies may be far more ordinary than the hype suggests.", "altids": {"mosaic": "36632fdb-3c80-4539-ab23-bb474615618e", "story": "e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "the-longevity-boom-is-moving-from-supplements-to-clinical-medicine"}, "subject": [{"name": "Technology", "rel": "direct", "literal": "technology", "code": "medtop:13000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/13000000"}], "place": [{"name": "United States", "literal": "us", "code": "US", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:59b01ae1-1c9b-4791-975f-dfb3aa45d49d", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "aarp.org", "copyrightnotice": "Image credit: Rory Doyle / AARP", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "59b01ae1-1c9b-4791-975f-dfb3aa45d49d"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "Reuse rights confirmed for editorial use", "licence_verified_at": "2026-08-21T20:19:06.051206Z", "attribution_required": true, "attribution_text": "Image credit: Rory Doyle / AARP", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "aarp.org", "source_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "source_page_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "our_page_url": "https://ascensio.uno/stile-di-vita/nel-2050-potremmo-non-vivere-150-anni-ma-invecchiare-molto-piu-tardi/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050-20260811", "status": "closed", "languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "item_count": 13, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Boldest Voice", "canonical_required": true, "canonical_url": "https://boldestvoice.com/technology/the-longevity-boom-is-moving-from-supplements-to-clinical-medicine/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 2, "official_source_used": false, "used_press_release": false, "public_interest": false, "ai_disclosure_required": false, "ai_disclosure_text": "", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-08-21T20:19:05.835284Z"}, "sources": [{"url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/", "title": "Source: Science Official", "publisher": "scienceofficial.org", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-21T20:19:05.829619Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT07290244", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.830015Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/innovation-models/cgt", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.830318Z", "published_at": null}]}, "wireva:publication": {"name": "Boldest Voice", "domain": "boldestvoice.com", "country": "US", "url": "https://boldestvoice.com/technology/the-longevity-boom-is-moving-from-supplements-to-clinical-medicine/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/36632fdb-3c80-4539-ab23-bb474615618e", "html": "https://wireva.mib.news/item/36632fdb-3c80-4539-ab23-bb474615618e/the-longevity-boom-is-moving-from-supplements-to-clinical-medicine/", "story": "https://wireva.mib.news/story/how-much-longer-could-humans-live-by-2050-20260811/"}, "wireva:metrics": {"word_count": 644, "char_count": 4390, "reading_time_seconds": 314}}}, "item-2": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:a809cd3b-469d-48e3-81be-d19a77109f9c", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T20:19:05.849244Z", "firstcreated": "2026-08-11T03:18:10.739531Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "If Medicine Slows Aging, Who Gets the Extra Years?", "byline": "Konstantin Schuster", "located": "Germany", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Hochland", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Hochland”. Set rel=canonical to https://hochland.uno/science/if-medicine-slows-aging-who-gets-the-extra-years/ when publishing on the web.", "description_text": "Longevity science is becoming a question not only of biology but of ethics, access and how society distributes technologies that could reshape old age.", "altids": {"mosaic": "a809cd3b-469d-48e3-81be-d19a77109f9c", "story": "e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "if-medicine-slows-aging-who-gets-the-extra-years"}, "subject": [{"name": "Health", "rel": "direct", "literal": "health", "code": "medtop:07000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/07000000"}], "place": [{"name": "Germany", "literal": "de", "code": "DE", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:96aed6a0-8143-4830-87ed-47e69f085140", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "nature.com", "copyrightnotice": "Browder et al. / Nature Aging / Springer Nature", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "96aed6a0-8143-4830-87ed-47e69f085140"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "Reuse rights confirmed for editorial use", "licence_verified_at": "2026-08-21T20:19:06.072558Z", "attribution_required": true, "attribution_text": "Browder et al. / Nature Aging / Springer Nature", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nature.com", "source_url": "https://www.nature.com/articles/s43587-022-00183-2", "source_page_url": "https://www.nature.com/articles/s43587-022-00183-2", "our_page_url": "https://pladrom.com/nauka/k-2050-godu-meditsina-mozhet-otodvinut-starost-no-ne-otmenit-ee/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://www.nature.com/articles/s43587-022-00183-2", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050-20260811", "status": "closed", "languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "item_count": 13, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Hochland", "canonical_required": true, "canonical_url": "https://hochland.uno/science/if-medicine-slows-aging-who-gets-the-extra-years/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 2, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "This item was produced with AI assistance under the editorial responsibility of Haydamax OU.", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-08-21T20:19:05.855976Z"}, "sources": [{"url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/", "title": "Source: Science Official", "publisher": "scienceofficial.org", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-21T20:19:05.850546Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT07290244", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.850917Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/innovation-models/cgt", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.851206Z", "published_at": null}]}, "wireva:publication": {"name": "Hochland", "domain": "hochland.uno", "country": "DE", "url": "https://hochland.uno/science/if-medicine-slows-aging-who-gets-the-extra-years/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/a809cd3b-469d-48e3-81be-d19a77109f9c", "html": "https://wireva.mib.news/item/a809cd3b-469d-48e3-81be-d19a77109f9c/if-medicine-slows-aging-who-gets-the-extra-years/", "story": "https://wireva.mib.news/story/how-much-longer-could-humans-live-by-2050-20260811/"}, "wireva:metrics": {"word_count": 640, "char_count": 4442, "reading_time_seconds": 317}}}, "item-3": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:790a3f52-615c-4e40-9a4b-ce14c798f426", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T20:19:05.870078Z", "firstcreated": "2026-08-11T03:18:10.776756Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "Longevity Could Become a Trillion-Dollar Healthcare Shift", "byline": "Callum Montgomery", "located": "United Kingdom", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Hublcore", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Hublcore”. Set rel=canonical to https://hublcore.com/business/longevity-could-become-a-trillion-dollar-healthcare-shift/ when publishing on the web.", "description_text": "The commercial prize in anti-aging medicine is not immortality. It is delaying several expensive diseases at once — but the business model depends on whether the winning therapies are pills or bespoke biology.", "altids": {"mosaic": "790a3f52-615c-4e40-9a4b-ce14c798f426", "story": "e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "longevity-could-become-a-trillion-dollar-healthcare-shift"}, "subject": [{"name": "Economy and business", "rel": "direct", "literal": "economy", "code": "medtop:04000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/04000000"}], "place": [{"name": "United Kingdom", "literal": "gb", "code": "GB", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:59b01ae1-1c9b-4791-975f-dfb3aa45d49d", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "aarp.org", "copyrightnotice": "Image credit: Rory Doyle / AARP", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "59b01ae1-1c9b-4791-975f-dfb3aa45d49d"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "Reuse rights confirmed for editorial use", "licence_verified_at": "2026-08-21T20:19:06.051206Z", "attribution_required": true, "attribution_text": "Image credit: Rory Doyle / AARP", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "aarp.org", "source_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "source_page_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "our_page_url": "https://ascensio.uno/stile-di-vita/nel-2050-potremmo-non-vivere-150-anni-ma-invecchiare-molto-piu-tardi/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050-20260811", "status": "closed", "languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "item_count": 13, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Hublcore", "canonical_required": true, "canonical_url": "https://hublcore.com/business/longevity-could-become-a-trillion-dollar-healthcare-shift/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 1, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "This item was produced with AI assistance under the editorial responsibility of Haydamax OU.", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-08-21T20:19:05.876413Z"}, "sources": [{"url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/", "title": "Source: Science Official", "publisher": "scienceofficial.org", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-21T20:19:05.871338Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/innovation-models/cgt", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.871706Z", "published_at": null}]}, "wireva:publication": {"name": "Hublcore", "domain": "hublcore.com", "country": "GB", "url": "https://hublcore.com/business/longevity-could-become-a-trillion-dollar-healthcare-shift/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/790a3f52-615c-4e40-9a4b-ce14c798f426", "html": "https://wireva.mib.news/item/790a3f52-615c-4e40-9a4b-ce14c798f426/longevity-could-become-a-trillion-dollar-healthcare-shift/", "story": "https://wireva.mib.news/story/how-much-longer-could-humans-live-by-2050-20260811/"}, "wireva:metrics": {"word_count": 508, "char_count": 3662, "reading_time_seconds": 262}}}, "item-4": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:0da5a2f5-f0d7-40b5-aed1-10a387784d77", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T20:19:05.890389Z", "firstcreated": "2026-08-11T03:18:10.808556Z", "pubstatus": "usable", "urgency": 5, "language": "en", "headline": "The Longevity Race Is Becoming an Infrastructure Race", "byline": "Nathan Fairchild", "located": "United Kingdom", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / The Bizzi Route", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / The Bizzi Route”. Set rel=canonical to https://thebizziroute.com/technology/the-longevity-race-is-becoming-an-infrastructure-race/ when publishing on the web.", "description_text": "By 2050, the countries that benefit most from aging technologies may be those that can manufacture vectors, cells and replacement organs at scale — not simply those with the richest early adopters.", "altids": {"mosaic": "0da5a2f5-f0d7-40b5-aed1-10a387784d77", "story": "e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "the-longevity-race-is-becoming-an-infrastructure-race"}, "subject": [{"name": "Technology", "rel": "direct", "literal": "technology", "code": "medtop:13000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/13000000"}], "place": [{"name": "United Kingdom", "literal": "gb", "code": "GB", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:96aed6a0-8143-4830-87ed-47e69f085140", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "nature.com", "copyrightnotice": "Browder et al. / Nature Aging / Springer Nature", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "96aed6a0-8143-4830-87ed-47e69f085140"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "Reuse rights confirmed for editorial use", "licence_verified_at": "2026-08-21T20:19:06.072558Z", "attribution_required": true, "attribution_text": "Browder et al. / Nature Aging / Springer Nature", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nature.com", "source_url": "https://www.nature.com/articles/s43587-022-00183-2", "source_page_url": "https://www.nature.com/articles/s43587-022-00183-2", "our_page_url": "https://pladrom.com/nauka/k-2050-godu-meditsina-mozhet-otodvinut-starost-no-ne-otmenit-ee/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://www.nature.com/articles/s43587-022-00183-2", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050-20260811", "status": "closed", "languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "item_count": 13, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / The Bizzi Route", "canonical_required": true, "canonical_url": "https://thebizziroute.com/technology/the-longevity-race-is-becoming-an-infrastructure-race/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 2, "official_source_used": false, "used_press_release": false, "public_interest": false, "ai_disclosure_required": false, "ai_disclosure_text": "", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-08-21T20:19:05.896929Z"}, "sources": [{"url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/", "title": "Source: Science Official", "publisher": "scienceofficial.org", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-21T20:19:05.891604Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT07290244", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.891987Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/innovation-models/cgt", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.892279Z", "published_at": null}]}, "wireva:publication": {"name": "The Bizzi Route", "domain": "thebizziroute.com", "country": "GB", "url": "https://thebizziroute.com/technology/the-longevity-race-is-becoming-an-infrastructure-race/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/0da5a2f5-f0d7-40b5-aed1-10a387784d77", "html": "https://wireva.mib.news/item/0da5a2f5-f0d7-40b5-aed1-10a387784d77/the-longevity-race-is-becoming-an-infrastructure-race/", "story": "https://wireva.mib.news/story/how-much-longer-could-humans-live-by-2050-20260811/"}, "wireva:metrics": {"word_count": 473, "char_count": 3379, "reading_time_seconds": 241}}}, "item-5": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:ffa064af-eb6f-4d87-9924-f2c0d63ae997", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T20:19:05.910573Z", "firstcreated": "2026-08-11T03:18:10.843668Z", "pubstatus": "usable", "urgency": 5, "language": "fr", "headline": "En 2050, vivre plus longtemps voudra surtout dire vieillir plus tard", "byline": "Céline Girard", "located": "France", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Cortex", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Cortex”. Set rel=canonical to https://cortex.luxe/science/en-2050-vivre-plus-longtemps-voudra-surtout-dire-vieillir-plus-tard/ when publishing on the web.", "description_text": "Les technologies du vieillissement passent progressivement des souris aux essais humains. Le scénario crédible n’est pas l’immortalité, mais plusieurs années de vie en bonne santé gagnées.", "altids": {"mosaic": "ffa064af-eb6f-4d87-9924-f2c0d63ae997", "story": "e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "en-2050-vivre-plus-longtemps-voudra-surtout-dire-vieillir-plus-tard"}, "subject": [{"name": "Science", "rel": "direct", "literal": "science", "code": "medtop:13000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/13000000"}], "place": [{"name": "France", "literal": "fr", "code": "FR", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:96aed6a0-8143-4830-87ed-47e69f085140", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "nature.com", "copyrightnotice": "Browder et al. / Nature Aging / Springer Nature", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "96aed6a0-8143-4830-87ed-47e69f085140"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "Reuse rights confirmed for editorial use", "licence_verified_at": "2026-08-21T20:19:06.072558Z", "attribution_required": true, "attribution_text": "Browder et al. / Nature Aging / Springer Nature", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nature.com", "source_url": "https://www.nature.com/articles/s43587-022-00183-2", "source_page_url": "https://www.nature.com/articles/s43587-022-00183-2", "our_page_url": "https://pladrom.com/nauka/k-2050-godu-meditsina-mozhet-otodvinut-starost-no-ne-otmenit-ee/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://www.nature.com/articles/s43587-022-00183-2", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050-20260811", "status": "closed", "languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "item_count": 13, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Cortex", "canonical_required": true, "canonical_url": "https://cortex.luxe/science/en-2050-vivre-plus-longtemps-voudra-surtout-dire-vieillir-plus-tard/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 2, "official_source_used": false, "used_press_release": false, "public_interest": false, "ai_disclosure_required": false, "ai_disclosure_text": "", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-08-21T20:19:05.917673Z"}, "sources": [{"url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/", "title": "Source : Science Official", "publisher": "scienceofficial.org", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-21T20:19:05.911966Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT07290244", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.912385Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/innovation-models/cgt", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.912699Z", "published_at": null}]}, "wireva:publication": {"name": "Cortex", "domain": "cortex.luxe", "country": "FR", "url": "https://cortex.luxe/science/en-2050-vivre-plus-longtemps-voudra-surtout-dire-vieillir-plus-tard/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/ffa064af-eb6f-4d87-9924-f2c0d63ae997", "html": "https://wireva.mib.news/item/ffa064af-eb6f-4d87-9924-f2c0d63ae997/en-2050-vivre-plus-longtemps-voudra-surtout-dire-vieillir-plus-tard/", "story": "https://wireva.mib.news/story/how-much-longer-could-humans-live-by-2050-20260811/"}, "wireva:metrics": {"word_count": 618, "char_count": 4356, "reading_time_seconds": 311}}}, "item-6": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:6cc2d8e7-b8a8-4a17-a296-1b9f5a312c61", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T20:19:05.931817Z", "firstcreated": "2026-08-11T03:18:10.878676Z", "pubstatus": "usable", "urgency": 5, "language": "fr", "headline": "La médecine de la longévité pourrait creuser puis réduire les inégalités", "byline": "Noémie Weber", "located": "France", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Udata", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Udata”. Set rel=canonical to https://udata.stream/societe/la-medecine-de-la-longevite-pourrait-creuser-puis-reduire-les-inegalites/ when publishing on the web.", "description_text": "Les premières thérapies de rajeunissement risquent d’être très coûteuses, mais les interventions les plus utiles pourraient ensuite entrer dans les systèmes de remboursement ordinaires.", "altids": {"mosaic": "6cc2d8e7-b8a8-4a17-a296-1b9f5a312c61", "story": "e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "la-medecine-de-la-longevite-pourrait-creuser-puis-reduire-les-inegalites"}, "subject": [{"name": "Society", "rel": "direct", "literal": "society", "code": "medtop:14000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/14000000"}], "place": [{"name": "France", "literal": "fr", "code": "FR", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:59b01ae1-1c9b-4791-975f-dfb3aa45d49d", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "aarp.org", "copyrightnotice": "Image credit: Rory Doyle / AARP", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "59b01ae1-1c9b-4791-975f-dfb3aa45d49d"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "Reuse rights confirmed for editorial use", "licence_verified_at": "2026-08-21T20:19:06.051206Z", "attribution_required": true, "attribution_text": "Image credit: Rory Doyle / AARP", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "aarp.org", "source_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "source_page_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "our_page_url": "https://ascensio.uno/stile-di-vita/nel-2050-potremmo-non-vivere-150-anni-ma-invecchiare-molto-piu-tardi/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050-20260811", "status": "closed", "languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "item_count": 13, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Udata", "canonical_required": true, "canonical_url": "https://udata.stream/societe/la-medecine-de-la-longevite-pourrait-creuser-puis-reduire-les-inegalites/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 1, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Cet article a été produit avec l’aide de l’IA sous la responsabilité éditoriale de Haydamax OU.", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-08-21T20:19:05.938113Z"}, "sources": [{"url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/", "title": "Source : Science Official", "publisher": "scienceofficial.org", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-21T20:19:05.933028Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/innovation-models/cgt", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.933402Z", "published_at": null}]}, "wireva:publication": {"name": "Udata", "domain": "udata.stream", "country": "FR", "url": "https://udata.stream/societe/la-medecine-de-la-longevite-pourrait-creuser-puis-reduire-les-inegalites/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/6cc2d8e7-b8a8-4a17-a296-1b9f5a312c61", "html": "https://wireva.mib.news/item/6cc2d8e7-b8a8-4a17-a296-1b9f5a312c61/la-medecine-de-la-longevite-pourrait-creuser-puis-reduire-les-inegalites/", "story": "https://wireva.mib.news/story/how-much-longer-could-humans-live-by-2050-20260811/"}, "wireva:metrics": {"word_count": 496, "char_count": 3444, "reading_time_seconds": 246}}}, "item-7": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:198dba95-74a1-48f6-8639-face5bfc212e", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T20:19:05.952983Z", "firstcreated": "2026-08-11T03:18:10.900180Z", "pubstatus": "usable", "urgency": 5, "language": "uk", "headline": "Ринок довголіття до 2050 року може розділитися на дешеві ліки й дорогу біоінженерію", "byline": "Данило Кравченко", "located": "Ukraine", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Карторг", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Карторг”. Set rel=canonical to https://cartorg.com.ua/tekhnologii/rinok-dovgolittia-do-2050-roku-mozhe-rozdilitisia-na-deshevi-liki-i-dorogu-bioinzheneriiu/ when publishing on the web.", "description_text": "Технології старіння переходять у клінічні випробування, але їхня бізнес-модель буде різною: від масових препаратів до генних терапій і заміни органів.", "altids": {"mosaic": "198dba95-74a1-48f6-8639-face5bfc212e", "story": "e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "rinok-dovgolittia-do-2050-roku-mozhe-rozdilitisia-na-deshevi-liki-i-dorogu-bioinzheneriiu"}, "subject": [{"name": "Economy and business", "rel": "direct", "literal": "economy", "code": "medtop:04000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/04000000"}], "place": [{"name": "Ukraine", "literal": "ua", "code": "UA", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:59b01ae1-1c9b-4791-975f-dfb3aa45d49d", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "aarp.org", "copyrightnotice": "Image credit: Rory Doyle / AARP", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "59b01ae1-1c9b-4791-975f-dfb3aa45d49d"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "Reuse rights confirmed for editorial use", "licence_verified_at": "2026-08-21T20:19:06.051206Z", "attribution_required": true, "attribution_text": "Image credit: Rory Doyle / AARP", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "aarp.org", "source_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "source_page_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "our_page_url": "https://ascensio.uno/stile-di-vita/nel-2050-potremmo-non-vivere-150-anni-ma-invecchiare-molto-piu-tardi/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050-20260811", "status": "closed", "languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "item_count": 13, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Карторг", "canonical_required": true, "canonical_url": "https://cartorg.com.ua/tekhnologii/rinok-dovgolittia-do-2050-roku-mozhe-rozdilitisia-na-deshevi-liki-i-dorogu-bioinzheneriiu/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 1, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Матеріал підготовлено за допомогою ШІ під редакційною відповідальністю Haydamax OU.", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-08-21T20:19:05.960688Z"}, "sources": [{"url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/", "title": "Джерело: Science Official", "publisher": "scienceofficial.org", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-21T20:19:05.954568Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/innovation-models/cgt", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.954985Z", "published_at": null}]}, "wireva:publication": {"name": "Карторг", "domain": "cartorg.com.ua", "country": "UA", "url": "https://cartorg.com.ua/tekhnologii/rinok-dovgolittia-do-2050-roku-mozhe-rozdilitisia-na-deshevi-liki-i-dorogu-bioinzheneriiu/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/198dba95-74a1-48f6-8639-face5bfc212e", "html": "https://wireva.mib.news/item/198dba95-74a1-48f6-8639-face5bfc212e/rinok-dovgolittia-do-2050-roku-mozhe-rozdilitisia-na-deshevi-liki-i-dorogu-bioinzheneriiu/", "story": "https://wireva.mib.news/story/how-much-longer-could-humans-live-by-2050-20260811/"}, "wireva:metrics": {"word_count": 395, "char_count": 3107, "reading_time_seconds": 222}}}, "item-8": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:a25b6739-ccea-48a4-a313-9a8034bcc289", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T20:19:05.977606Z", "firstcreated": "2026-08-11T03:18:10.918627Z", "pubstatus": "usable", "urgency": 5, "language": "uk", "headline": "Технології довголіття переходять від лабораторії до бізнес-моделі", "byline": "Роман Мельничук", "located": "Ukraine", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Віндор", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Віндор”. Set rel=canonical to https://vindor.com.ua/tekhnologii/tekhnologii-dovgolittia-perekhodiat-vid-laboratorii-do-biznes-modeli/ when publishing on the web.", "description_text": "До 2050 року масовими можуть стати недорогі геропротектори, тоді як генні та клітинні процедури ще довго залишатимуться преміальними.", "altids": {"mosaic": "a25b6739-ccea-48a4-a313-9a8034bcc289", "story": "e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "tekhnologii-dovgolittia-perekhodiat-vid-laboratorii-do-biznes-modeli"}, "subject": [{"name": "Economy and business", "rel": "direct", "literal": "economy", "code": "medtop:04000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/04000000"}], "place": [{"name": "Ukraine", "literal": "ua", "code": "UA", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:85685646-a2ae-4f53-bd13-39a9bef80061", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "pmc.ncbi.nlm.nih.gov", "copyrightnotice": "International Journal of Molecular Sciences / NCBI PMC", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "85685646-a2ae-4f53-bd13-39a9bef80061"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "Reuse rights confirmed for editorial use", "licence_verified_at": "2026-08-21T20:19:06.030373Z", "attribution_required": true, "attribution_text": "International Journal of Molecular Sciences / NCBI PMC", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "pmc.ncbi.nlm.nih.gov", "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10650750/", "source_page_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10650750/", "our_page_url": "https://evolut.top/sociedad/la-longevidad-cambia-de-promesa-vivir-mas-empieza-a-significar-envejecer-mejor/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10650750/", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050-20260811", "status": "closed", "languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "item_count": 13, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Віндор", "canonical_required": true, "canonical_url": "https://vindor.com.ua/tekhnologii/tekhnologii-dovgolittia-perekhodiat-vid-laboratorii-do-biznes-modeli/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 2, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Матеріал підготовлено за допомогою ШІ під редакційною відповідальністю Haydamax OU.", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-08-21T20:19:05.985173Z"}, "sources": [{"url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/", "title": "Джерело: Science Official", "publisher": "scienceofficial.org", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-21T20:19:05.979091Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT07290244", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.979556Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/innovation-models/cgt", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:05.979936Z", "published_at": null}]}, "wireva:publication": {"name": "Віндор", "domain": "vindor.com.ua", "country": "UA", "url": "https://vindor.com.ua/tekhnologii/tekhnologii-dovgolittia-perekhodiat-vid-laboratorii-do-biznes-modeli/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/a25b6739-ccea-48a4-a313-9a8034bcc289", "html": "https://wireva.mib.news/item/a25b6739-ccea-48a4-a313-9a8034bcc289/tekhnologii-dovgolittia-perekhodiat-vid-laboratorii-do-biznes-modeli/", "story": "https://wireva.mib.news/story/how-much-longer-could-humans-live-by-2050-20260811/"}, "wireva:metrics": {"word_count": 339, "char_count": 2798, "reading_time_seconds": 200}}}, "item-9": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:5876c490-5be4-4493-8a92-e3db4285ca95", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T20:19:05.999862Z", "firstcreated": "2026-08-11T03:18:10.938038Z", "pubstatus": "usable", "urgency": 5, "language": "de", "headline": "Werden wir 2050 wirklich viel älter – oder nur später alt?", "byline": "Moritz Albrecht", "located": "Germany", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Junkr", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Junkr”. Set rel=canonical to https://junkr.party/technologie/werden-wir-2050-wirklich-viel-alter-oder-nur-spater-alt/ when publishing on the web.", "description_text": "Anti-Aging wird wissenschaftlicher: Medikamente, Zellreparatur und Reprogrammierung kommen näher an Menschen. 150 Jahre bleiben trotzdem extrem unwahrscheinlich.", "altids": {"mosaic": "5876c490-5be4-4493-8a92-e3db4285ca95", "story": "e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "werden-wir-2050-wirklich-viel-alter-oder-nur-spater-alt"}, "subject": [{"name": "Technology", "rel": "direct", "literal": "technology", "code": "medtop:13000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/13000000"}], "place": [{"name": "Germany", "literal": "de", "code": "DE", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:59b01ae1-1c9b-4791-975f-dfb3aa45d49d", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "aarp.org", "copyrightnotice": "Image credit: Rory Doyle / AARP", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "59b01ae1-1c9b-4791-975f-dfb3aa45d49d"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "Reuse rights confirmed for editorial use", "licence_verified_at": "2026-08-21T20:19:06.051206Z", "attribution_required": true, "attribution_text": "Image credit: Rory Doyle / AARP", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "aarp.org", "source_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "source_page_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "our_page_url": "https://ascensio.uno/stile-di-vita/nel-2050-potremmo-non-vivere-150-anni-ma-invecchiare-molto-piu-tardi/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050-20260811", "status": "closed", "languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "item_count": 13, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Junkr", "canonical_required": true, "canonical_url": "https://junkr.party/technologie/werden-wir-2050-wirklich-viel-alter-oder-nur-spater-alt/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 2, "official_source_used": false, "used_press_release": false, "public_interest": false, "ai_disclosure_required": false, "ai_disclosure_text": "", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-08-21T20:19:06.006809Z"}, "sources": [{"url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/", "title": "Quelle: Science Official", "publisher": "scienceofficial.org", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-21T20:19:06.001180Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT07290244", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:06.001565Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/innovation-models/cgt", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:06.001928Z", "published_at": null}]}, "wireva:publication": {"name": "Junkr", "domain": "junkr.party", "country": "DE", "url": "https://junkr.party/technologie/werden-wir-2050-wirklich-viel-alter-oder-nur-spater-alt/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/5876c490-5be4-4493-8a92-e3db4285ca95", "html": "https://wireva.mib.news/item/5876c490-5be4-4493-8a92-e3db4285ca95/werden-wir-2050-wirklich-viel-alter-oder-nur-spater-alt/", "story": "https://wireva.mib.news/story/how-much-longer-could-humans-live-by-2050-20260811/"}, "wireva:metrics": {"word_count": 464, "char_count": 3711, "reading_time_seconds": 265}}}, "item-10": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:0bf7a57d-e239-4ff1-beb3-25d6a03b1fd8", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T20:19:06.021353Z", "firstcreated": "2026-08-11T03:18:10.957212Z", "pubstatus": "usable", "urgency": 5, "language": "es", "headline": "La longevidad cambia de promesa: vivir más empieza a significar envejecer mejor", "byline": "Elena Lozano", "located": "Spain", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Evolut", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Evolut”. Set rel=canonical to https://evolut.top/sociedad/la-longevidad-cambia-de-promesa-vivir-mas-empieza-a-significar-envejecer-mejor/ when publishing on the web.", "description_text": "La ciencia del envejecimiento avanza hacia ensayos humanos, pero el horizonte de 2050 apunta más a retrasar la fragilidad que a normalizar vidas de 150 años.", "altids": {"mosaic": "0bf7a57d-e239-4ff1-beb3-25d6a03b1fd8", "story": "e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "la-longevidad-cambia-de-promesa-vivir-mas-empieza-a-significar-envejecer-mejor"}, "subject": [{"name": "Society", "rel": "direct", "literal": "society", "code": "medtop:14000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/14000000"}], "place": [{"name": "Spain", "literal": "es", "code": "ES", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:85685646-a2ae-4f53-bd13-39a9bef80061", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "pmc.ncbi.nlm.nih.gov", "copyrightnotice": "International Journal of Molecular Sciences / NCBI PMC", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "85685646-a2ae-4f53-bd13-39a9bef80061"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "Reuse rights confirmed for editorial use", "licence_verified_at": "2026-08-21T20:19:06.030373Z", "attribution_required": true, "attribution_text": "International Journal of Molecular Sciences / NCBI PMC", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "pmc.ncbi.nlm.nih.gov", "source_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10650750/", "source_page_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10650750/", "our_page_url": "https://evolut.top/sociedad/la-longevidad-cambia-de-promesa-vivir-mas-empieza-a-significar-envejecer-mejor/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://pmc.ncbi.nlm.nih.gov/articles/PMC10650750/", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050-20260811", "status": "closed", "languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "item_count": 13, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Evolut", "canonical_required": true, "canonical_url": "https://evolut.top/sociedad/la-longevidad-cambia-de-promesa-vivir-mas-empieza-a-significar-envejecer-mejor/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 2, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Este artículo se ha producido con ayuda de IA bajo la responsabilidad editorial de Haydamax OU.", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-08-21T20:19:06.028298Z"}, "sources": [{"url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/", "title": "Fuente: Science Official", "publisher": "scienceofficial.org", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-21T20:19:06.022686Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT07290244", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:06.023068Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/innovation-models/cgt", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:06.023377Z", "published_at": null}]}, "wireva:publication": {"name": "Evolut", "domain": "evolut.top", "country": "ES", "url": "https://evolut.top/sociedad/la-longevidad-cambia-de-promesa-vivir-mas-empieza-a-significar-envejecer-mejor/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/0bf7a57d-e239-4ff1-beb3-25d6a03b1fd8", "html": "https://wireva.mib.news/item/0bf7a57d-e239-4ff1-beb3-25d6a03b1fd8/la-longevidad-cambia-de-promesa-vivir-mas-empieza-a-significar-envejecer-mejor/", "story": "https://wireva.mib.news/story/how-much-longer-could-humans-live-by-2050-20260811/"}, "wireva:metrics": {"word_count": 500, "char_count": 3560, "reading_time_seconds": 254}}}, "item-11": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:7a6cac2f-078a-4fe1-a3e2-f0813d0072d4", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T20:19:06.042462Z", "firstcreated": "2026-08-11T03:18:10.992567Z", "pubstatus": "usable", "urgency": 5, "language": "it", "headline": "Nel 2050 potremmo non vivere 150 anni, ma invecchiare molto più tardi", "byline": "Alessia Amato", "located": "Italy", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Ascensio", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Ascensio”. Set rel=canonical to https://ascensio.uno/stile-di-vita/nel-2050-potremmo-non-vivere-150-anni-ma-invecchiare-molto-piu-tardi/ when publishing on the web.", "description_text": "Farmaci, riprogrammazione cellulare e organi ingegnerizzati stanno entrando nella medicina. Il risultato più realistico è guadagnare anni in salute, non l’immortalità.", "altids": {"mosaic": "7a6cac2f-078a-4fe1-a3e2-f0813d0072d4", "story": "e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "nel-2050-potremmo-non-vivere-150-anni-ma-invecchiare-molto-piu-tardi"}, "subject": [{"name": "Lifestyle", "rel": "direct", "literal": "lifestyle", "code": "medtop:10000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/10000000"}], "place": [{"name": "Italy", "literal": "it", "code": "IT", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:59b01ae1-1c9b-4791-975f-dfb3aa45d49d", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "aarp.org", "copyrightnotice": "Image credit: Rory Doyle / AARP", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "59b01ae1-1c9b-4791-975f-dfb3aa45d49d"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "Reuse rights confirmed for editorial use", "licence_verified_at": "2026-08-21T20:19:06.051206Z", "attribution_required": true, "attribution_text": "Image credit: Rory Doyle / AARP", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "aarp.org", "source_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "source_page_url": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "our_page_url": "https://ascensio.uno/stile-di-vita/nel-2050-potremmo-non-vivere-150-anni-ma-invecchiare-molto-piu-tardi/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://www.aarp.org/espanol/salud/farmacos-y-suplementos/info-2023/pastilla-para-retrasar-envejecimiento.html", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050-20260811", "status": "closed", "languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "item_count": 13, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Ascensio", "canonical_required": true, "canonical_url": "https://ascensio.uno/stile-di-vita/nel-2050-potremmo-non-vivere-150-anni-ma-invecchiare-molto-piu-tardi/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 2, "official_source_used": false, "used_press_release": false, "public_interest": false, "ai_disclosure_required": false, "ai_disclosure_text": "", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-08-21T20:19:06.049287Z"}, "sources": [{"url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/", "title": "Fonte: Science Official", "publisher": "scienceofficial.org", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-21T20:19:06.043680Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT07290244", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:06.044040Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/innovation-models/cgt", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:06.044345Z", "published_at": null}]}, "wireva:publication": {"name": "Ascensio", "domain": "ascensio.uno", "country": "IT", "url": "https://ascensio.uno/stile-di-vita/nel-2050-potremmo-non-vivere-150-anni-ma-invecchiare-molto-piu-tardi/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/7a6cac2f-078a-4fe1-a3e2-f0813d0072d4", "html": "https://wireva.mib.news/item/7a6cac2f-078a-4fe1-a3e2-f0813d0072d4/nel-2050-potremmo-non-vivere-150-anni-ma-invecchiare-molto-piu-tardi/", "story": "https://wireva.mib.news/story/how-much-longer-could-humans-live-by-2050-20260811/"}, "wireva:metrics": {"word_count": 465, "char_count": 3366, "reading_time_seconds": 240}}}, "item-12": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:a1be06f6-33ed-4744-9e1a-f624aa232e3f", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T20:19:06.063504Z", "firstcreated": "2026-08-11T03:18:11.028006Z", "pubstatus": "usable", "urgency": 5, "language": "ru", "headline": "К 2050 году медицина может отодвинуть старость, но не отменить ее", "byline": "Вера Ершова", "located": "RU", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Пладром", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Пладром”. Set rel=canonical to https://pladrom.com/nauka/k-2050-godu-meditsina-mozhet-otodvinut-starost-no-ne-otmenit-ee/ when publishing on the web.", "description_text": "Исследования старения переходят в клинику: тестируются геропротекторы, сенолитики, генное редактирование и частичное перепрограммирование клеток. Реалистичный сценарий — годы здоровой жизни, а не 150-летие.", "altids": {"mosaic": "a1be06f6-33ed-4744-9e1a-f624aa232e3f", "story": "e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "k-2050-godu-meditsina-mozhet-otodvinut-starost-no-ne-otmenit-ee"}, "subject": [{"name": "Health", "rel": "direct", "literal": "health", "code": "medtop:07000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/07000000"}], "place": [{"name": "RU", "literal": "ru", "code": "RU", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:96aed6a0-8143-4830-87ed-47e69f085140", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "", "description_text": "", "copyrightholder": "nature.com", "copyrightnotice": "Browder et al. / Nature Aging / Springer Nature", "usageterms": "Picture belongs to the source publication: address and terms are delivered, the file is not.", "altids": {"wireva": "96aed6a0-8143-4830-87ed-47e69f085140"}, "extra": {"wireva:delivery_mode": "link_only", "wireva:rights": {"licence": "", "licence_url": "", "licence_raw": "Reuse rights confirmed for editorial use", "licence_verified_at": "2026-08-21T20:19:06.072558Z", "attribution_required": true, "attribution_text": "Browder et al. / Nature Aging / Springer Nature", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nature.com", "source_url": "https://www.nature.com/articles/s43587-022-00183-2", "source_page_url": "https://www.nature.com/articles/s43587-022-00183-2", "our_page_url": "https://pladrom.com/nauka/k-2050-godu-meditsina-mozhet-otodvinut-starost-no-ne-otmenit-ee/"}, "wireva:role": "lead"}, "renditions": {"source": {"href": "https://www.nature.com/articles/s43587-022-00183-2", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:e90e2267-f562-4611-91f0-1a25f7adc083", "slug": "how-much-longer-could-humans-live-by-2050-20260811", "status": "closed", "languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "item_count": 13, "is_breaking": false}, "wireva:rights": {"class": "agency_original", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Пладром", "canonical_required": true, "canonical_url": "https://pladrom.com/nauka/k-2050-godu-meditsina-mozhet-otodvinut-starost-no-ne-otmenit-ee/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "agency_original_unassessed_allow", "needs_review": true}, "wireva:provenance": {"production_method": "automated", "ai_stages": {}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "multi_source", "independent_confirmations": 2, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Материал подготовлен с помощью ИИ под редакционной ответственностью Haydamax OU.", "independence_check": {"status": "not_assessed", "score": 0.0, "checked_at": "2026-08-21T20:19:06.070605Z"}, "sources": [{"url": "https://scienceofficial.org/science/how-much-longer-could-humans-live-by-2050/", "title": "Источник: Science Official", "publisher": "scienceofficial.org", "type": "rss", "role": "primary", "official": false, "retrieved_at": "2026-08-21T20:19:06.065028Z", "published_at": null}, {"url": "https://clinicaltrials.gov/study/NCT07290244", "title": "", "publisher": "clinicaltrials.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:06.065416Z", "published_at": null}, {"url": "https://www.cms.gov/priorities/innovation/innovation-models/cgt", "title": "", "publisher": "cms.gov", "type": "rss", "role": "supporting", "official": false, "retrieved_at": "2026-08-21T20:19:06.065715Z", "published_at": null}]}, "wireva:publication": {"name": "Пладром", "domain": "pladrom.com", "country": "RU", "url": "https://pladrom.com/nauka/k-2050-godu-meditsina-mozhet-otodvinut-starost-no-ne-otmenit-ee/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/a1be06f6-33ed-4744-9e1a-f624aa232e3f", "html": "https://wireva.mib.news/item/a1be06f6-33ed-4744-9e1a-f624aa232e3f/k-2050-godu-meditsina-mozhet-otodvinut-starost-no-ne-otmenit-ee/", "story": "https://wireva.mib.news/story/how-much-longer-could-humans-live-by-2050-20260811/"}, "wireva:metrics": {"word_count": 467, "char_count": 3981, "reading_time_seconds": 284}}}}, "extra": {"wireva:languages": ["de", "en", "es", "fr", "it", "ru", "uk"], "wireva:status": "closed", "wireva:item_count": 13}}